⌘K
Loading ticker…
ResMed Inc. · Healthcare · Medical Equipment
As of 2026-06-26, ResMed Inc. (RMD) has a 3-month relative strength percentile of 26 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 43. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.7%, relative volume 1.25×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
26 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
RMD is in a stage 4 downtrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -1.6% / -16.7%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
RMD is held by 23 ETFs as of Mar 2026. Top owner: VTI at 0.05% weight, $1.0B notional. Top 3 carry $2.6B.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.05% | $1.0B |
| VOOVanguard S&P 500 ETF | 0.06% | $831M |
| VOVanguard Mid-Cap ETF | 0.36% | $706M |
| IVViShares Core S&P 500 ETF | 0.06% | $421M |
| VUGVanguard Growth ETF | 0.12% | $393M |
| SPYState Street SPDR S&P 500 ETF | 0.06% | $381M |
| VOTVanguard Mid-Cap Growth ETF | 0.85% | $249M |
| XLVState Street Health Care Select Sector SPDR ETF | 0.62% | $238M |
| IWRiShares Russell Midcap ETF | 0.26% | $125M |
| SPYMState Street SPDR Portfolio S&P 500 ETF | 0.06% | $69M |
Showing 10 of 23 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RMD Jan avg: 7.70% median: 8.48% win: 100% σ: 3.27% n: 4 2022-04-12 → 2026-05-29 | RMD Feb avg: -4.33% median: -3.93% win: 0% σ: 3.97% n: 4 2022-04-12 → 2026-05-29 | RMD Mar avg: 0.07% median: -0.66% win: 50% σ: 11.18% n: 4 2022-04-12 → 2026-05-29 | RMD Apr avg: 0.32% median: 5.69% win: 60% σ: 11.44% n: 5 2022-04-12 → 2026-05-29 | RMD May avg: -4.35% median: -3.58% win: 40% σ: 7.21% n: 5 2022-04-12 → 2026-05-29 | RMD Jun avg: 1.21% median: 3.35% win: 75% σ: 5.72% n: 4 2022-04-12 → 2026-05-29 (current) | RMD Jul avg: 8.33% median: 8.40% win: 100% σ: 5.84% n: 4 2022-04-12 → 2026-05-29 | RMD Aug avg: -5.24% median: -3.81% win: 50% σ: 18.10% n: 4 2022-04-12 → 2026-05-29 | RMD Sep avg: -2.18% median: -0.55% win: 0% σ: 3.45% n: 4 2022-04-12 → 2026-05-29 | RMD Oct avg: -3.13% median: -2.59% win: 25% σ: 5.29% n: 4 2022-04-12 → 2026-05-29 | RMD Nov avg: 5.23% median: 3.27% win: 100% σ: 4.32% n: 4 2022-04-12 → 2026-05-29 | RMD Dec avg: -3.64% median: -7.01% win: 25% σ: 8.60% n: 4 2022-04-12 → 2026-05-29 |